Skip to main content

Table 1 Baseline characteristics of patients in the full analysis set population

From: Hydrogen/oxygen therapy for the treatment of an acute exacerbation of chronic obstructive pulmonary disease: results of a multicenter, randomized, double-blind, parallel-group controlled trial

Characteristic

Oxygen group (n = 54)

Hydrogen/oxygen group (n = 53)

P value

Age-year, mean(SD)

69.8 (8.23)

69.7 (7.72)

0.959

Male sex-n (%)

46 (85.2%)

48 (90.6%)

0.556

Height-cm, mean (SD)

164.7 (6.86)

167.0 (6.98)

0.092

Weight-kg, mean (SD)

60.05 (9.86)

63.52 (12.87)

0.120

BMI-kg/m2,mean (SD)

22.15 (3.47)

22.74 (4.09)

0.421

History of Smoking, yes-n (%)

42 (77.8%)

45 (84.9%)

0.667

Average smoking amount/day, mean (SD)

16.4 (8.97)

24.8 (16.40)

0.127

Disease history, yes-n (%)

51 (94.4%)

49 (92.5%)

0.716

Clinical symptoms, yes-n (%)

 Aggravated wheezing

52 (96.3%)

48 (90.6%)

0.270

 Increased sputum production

37 (68.5%)

35 (66.0%)

0.838

 Sputum purulence

24 (44.4%)

21 (39.6%)

0.696

 Fever

2 (6.9%)

1 (3.8%)

> 0.999

 Aggravated cough

28 (96.6%)

24 (92.3%)

0.598

 Increased wheezing rale

7 (24.1%)

6 (23.1%)

> 0.999

 Increased breathing and heart rate (≥ 20% from baseline)

0 (0.0%)

1 (3.8%)

0.473

 Sore throat or rhinorrhea with 5 days

1 (3.4%)

0 (0.0%)

> 0.999

  1. BMI body mass index, SD standard deviation